Table 3 Radical treatment within 1 year of being diagnosed with prostate cancer according to the Cambridge Prognostic Group (CPG)
Patients (n) | Radical Tx (%) | Adj. RR | 95% CI | P | |
|---|---|---|---|---|---|
CPG | |||||
1 | 10,963 | 1236 (11.3) | 0.23 | 0.18–0.30 | < 0.001 |
2 | 13,587 | 6580 (48.4) | 1 | ||
3 | 9449 | 6263 (66.3) | 1.44 | 1.36–1.53 | |
4 | 12,828 | 10,112 (78.8) | 1.69 | 1.32–2.15 | |
5 | 15,160 | 11,118 (73.3) | 1.70 | 1.37–2.11 | |
Age group (years) | |||||
< 60 | 8987 | 5195 (57.8) | 1 | < 0.001 | |
60–69 | 24,343 | 14,843 (61.0) | 0.91 | 0.82–1.01 | |
70–79 | 23,972 | 14,073 (58.7) | 0.78 | 0.70–0.88 | |
≥ 80 | 4685 | 1198 (25.6) | 0.31 | 0.22–0.44 | |
Number of comorbidities (RCS Charlson score) | |||||
0 | 47,960 | 27,921 (58.2) | 1 | 0.011 | |
1 | 9460 | 5159 (54.5) | 0.95 | 0.73–1.24 | |
≥ 2 | 4567 | 2229 (48.8) | 0.85 | 0.51–1.44 | |
Socioeconomic deprivation status (5th of national distribution) | |||||
1 (least deprived) | 14,825 | 8525 (57.5) | 1 | 0.267 | |
2 | 14,571 | 8309 (57.0) | 0.98 | 0.92–1.04 | |
3 | 13,027 | 7428 (57.0) | 0.98 | 0.88–1.08 | |
4 | 10,666 | 6067 (56.9) | 0.97 | 0.49–1.76 | |
5 (most deprived) | 8898 | 4980 (56.0) | 0.93 | 0.60–1.60 | |
Ethnicity | |||||
White | 57,581 | 32,838 (57.0) | 1 | 0.908 | |
Non-white | 4406 | 2471 (56.0) | 0.98 | 0.87–1.13 | |